Association Between Statin Medications and COPD-Specific Outcomes: A Real-World Observational Study. - Wikidata - awgldk - TriplyDB

Association Between Statin Medications and COPD-Specific Outcomes: A Real-World Observational Study.

Association Between Statin Medications and COPD-Specific Outcomes: A Real-World Observational Study.

http://www.wikidata.org/entity/Q37675233

about

Statins reduce all-cause mortality in chronic obstructive pulmonary disease: an updated systematic review and meta-analysis of observational studies.

P2860

Q42700712-EC63457A-01D2-42E7-962C-EB0FF4847D24

P2860

Association Between Statin Medications and COPD-Specific Outcomes: A Real-World Observational Study.

http://www.wikidata.org/entity/Q37675233

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Association Between Statin Med ...... eal-World Observational Study.

@en

Association Between Statin Med ...... eal-World Observational Study.

@nl

type

label

Association Between Statin Med ...... eal-World Observational Study.

@en

Association Between Statin Med ...... eal-World Observational Study.

@nl

prefLabel

Association Between Statin Med ...... eal-World Observational Study.

@en

Association Between Statin Med ...... eal-World Observational Study.

@nl

P1433

Q37675233-F66D8F80-D2D9-4380-AFCE-70FB9A03F7C4

P1476

Q37675233-7665D9A7-3A76-4A66-95E0-D8F445B695FF

P2093

Q37675233-186B87E5-ABC0-4121-A324-A66A656E0DA7

Q37675233-2D4B7001-5399-4784-BB25-A02B93FAE79F

Q37675233-FEF6A671-7042-46E3-BD42-04A491A41BF2

P2860

Q37675233-10336DBE-58EC-4767-8DA8-E1CE95CA4455

Q37675233-32576224-C318-45E2-A308-1ADD9306AF25

Q37675233-3C518FFA-CF31-4AE4-8BAA-EE04F4D9C197

Q37675233-3CC8F14E-CE5E-47B0-9248-8E402A92B7A8

Q37675233-3E8FF0B7-21B3-490F-86A8-F6B31481BF31

Q37675233-45D61F79-A732-4EA7-A788-8C2A43C27517

Q37675233-619A5646-5D79-4608-A9FD-6B9E43BF7C58

Q37675233-63186FD5-E1E5-433C-8FCD-B2D640319ECE

Q37675233-71260899-080E-4BD4-908B-AAFE410DDC02

Q37675233-7561E0E0-164C-44C5-8254-C3C2B1F51CFC

P2888

Q37675233-15329513-D65B-4C40-917D-C786C9E22CB4

P304

Q37675233-49B85D05-1138-47D1-9E14-F280F1BEAF6C

P31

Q37675233-B79926AA-9862-4632-818E-3D17AE121FAB

P356

Q37675233-B55A85E3-3B42-4490-BE87-14A53BA17223

P433

Q37675233-D1D60916-92FE-45EF-9D7B-F9DE549421F4

P478

Q37675233-B1E93A0A-A929-470F-A388-33FC28E6E83A

P577

Q37675233-7B4EBC56-6237-470A-B4F6-9E22D88CBD84

P698

Q37675233-CAC7BF42-1314-4141-9F4E-9AA3FEA1630D

P921

Q37675233-21CF5F0B-C959-46DA-82A1-E998641BD5AB

P932

Q37675233-29D835DA-199C-494F-9C9E-D6A008BCB14E

P356

S40801-016-0101-6

P1433

Drugs - real world outcomes

P1476

Association Between Statin Med ...... eal-World Observational Study.

@en

P2093

Chan Shen

http://www.w3.org/2001/XMLSchema#string

Mayank Ajmera

http://www.w3.org/2001/XMLSchema#string

Usha Sambamoorthi

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease.

The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008.

Simvastatin for the prevention of exacerbations in moderate-to-severe COPD

Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype?

Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease.

Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?

The inflammation hypothesis and its potential relevance to statin therapy.

Inhaled anticholinergic use and all-cause mortality among elderly Medicare beneficiaries with chronic obstructive pulmonary disease.

Treating systemic effects of COPD.

P2888

s40801-016-0101-6

P304

9-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40801-016-0101-6

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27943058

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

5332305

http://www.w3.org/2001/XMLSchema#string